Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference
Provided By PR Newswire
Last update: Aug 27, 2025
EMERYVILLE, Calif., Aug. 27, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will participate in a fireside chat at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3rd at 4:30 p.m. ET.
Read more at prnewswire.com
